{
  "id": 211,
  "text": "The European Gyn GEC ESTRO group has become the major driving force in this development, providing essential recommendations to guide this treatment as early as 2005 and 2006.This group also started large multi-center retrospective and prospective clinical trials and evaluations of image guided adaptive brachytherapy (RetroEMBRACE, EMBRACE I (2008-2015) and EMBRACE II (since 2016)) benchmarking these innovations in a multicentre clinical setting13.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: The European Gyn GEC ESTRO group has become the major driving force in this development, providing essential recommendations to guide this treatment as early as 2005 and 2006.This group also started large multi-center retrospective and prospective clinical trials and evaluations of image guided adaptive brachytherapy (RetroEMBRACE, EMBRACE I (2008-2015) and EMBRACE II (since 2016)) benchmarking th\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "自2005年以来，European Gyn GEC ESTRO小组主导了图像引导自适应近距离放疗的发展。这个组织不仅提供了指导这一治疗的重要建议，还启动了多中心的临床试验，包括RetroEMBRACE、EMBRACE I（2008-2015）和EMBRACE II（自2016年起）。这些试验在多中心临床环境中进行，为该领域的发展奠定了基准。",
  "query": "自2005年以来，哪个组织主导了图像引导自适应近距离放疗的发展，并启动了多中心临床试验？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 自2005年以来，哪个组织主导了图像引导自适应近距离放疗的发展，并启动了多中心临床试验？\n\n<reference text>: The European Gyn GEC ESTRO group has become the major driving force in this development, providing essential recommendations to guide this treatment as early as 2005 and 2006.This group also started large multi-center retrospective and prospective clinical trials and evaluations of image guided adaptive brachytherapy (RetroEMBRACE, EMBRACE I (2008-2015) and EMBRACE II (since 2016)) benchmarking these innovations in a multicentre clinical setting13.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "自2005年以来，European Gyn GEC ESTRO小组主导了图像引导自适应近距离放疗的发展。这个组织不仅提供了指导这一治疗的重要建议，还启动了多中心的临床试验，包括RetroEMBRACE、EMBRACE I（2008-2015）和EMBRACE II（自2016年起）。这些试验在多中心临床环境中进行，为该领域的发展奠定了基准。"
}